https://idataresearch.com/wp-content/themes/lambda-child-theme/images/footer-logo.png
https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Breast Reconstruction

Showing all 8 results

Soft Tissue Repair Market Analysis, Size, Trends | Europe | 2018-2024 | MedSuite | Includes: Breast Reconstruction, Hernia Repair, Dural Repair and more

Overall, the European soft tissue repair market is expected to increase at a CAGR of 1.8% to reach nearly $520 million by 2024. If there is one factor that affects nearly every segment in this report, it’s an aging population. The demographic of those over the age of 65 is increasing in Europe, which leads

more...

Soft Tissue Repair Market Analysis, Size, Trends | United States | 2020-2026 | COVID19 | MedSuite

In 2020, the U.S. soft tissue repair market size was valued at $1.8 billion, with over 1 million hernia repair procedures performed every year. The overall market size is expected to increase at a compound annual growth rate (CAGR) of 7.8% to reach $3.1 billion in 2026. Throughout this medical market research, we analyzed 37

more...

Soft Tissue Repair Market Analysis, Size, Trends | 2018-2024 | MedSuite

Industry Trends Soft tissue repair devices are gaining popularity in the U.S. due to the rising awareness of their clinical history among surgeons. Furthermore, the growing and aging population, and the associated demand for soft tissue repair procedures, are expected to fuel the expansion of the soft tissue augmentation and reinforcement device in the U.S.

more...

Breast Reconstruction Market | Europe | 2018-2024 | MedCore

The total breast reconstruction market is expected to show moderate growth in upcoming years, fueled by the continuing success of biologics, especially LifeCell’s Strattice™, which has been showing substantial growth since its introduction to the European market. The outstanding clinical reviews and patient satisfaction garnered by biologic matrices will allow Strattice™ to continue to be

more...

Breast Reconstruction Market Analysis | United States | 2020-2026 | MedCore

Breast reconstruction following mastectomy for treatment of cancer is becoming increasingly popular in the United States. Breast reconstruction is a plastic surgery procedure in which the shape of the breast is rebuilt. The number of these reconstructive procedures represents less than 30% of plastic surgery breast augmentation procedures. Breast reconstruction is typically performed after mastectomy, although not all mastectomy patients elect to have reconstructive surgery. Elderly patients are not only less likely to opt for breast reconstruction surgery, but are less likely to proceed with a mastectomy following breast cancer diagnosis. The incidence of breast cancer has been increasing in women under the age of 40, and this population is much more likely not only to proceed with mastectomy, but to follow up with a breast reconstruction procedure. Over 130,000 mastectomies were performed in the U.S. in 2016, and of these, over 70% of patients elected for breast reconstruction surgery. This percentage was significantly higher in the U.S. compared with other countries. Therefore, in the United States, the number of breast reconstruction procedures is highly correlated with the number of mastectomies performed. The Women’s Health and Cancer Rights Act (WHCRA), established in 1998, ensures full reimbursement for most procedures done on women with breast cancer who elect to have their breasts rebuilt following mastectomy. The procedure is extremely involved and is done in an inpatient setting. Breast reconstructions have started to be conducted immediately after the mastectomy procedure to reduce recovery time.

more...

Breast Tissue Markets and Breast Localization Wires Market Report Suite | United States | 2016-2022 | MedSuite

Growth will be driven by the aging U.S. population, increased mammogram procedure volume and improvement in mammogram quality. The rising volume of diagnoses will drive an increase in the number of patients requiring treatment, applying upward pressure to breast tissue marker unit sales and limiting the decline in breast localization wire unit sales over the forecast period.

more...

Breast Localization Wires Market Analysis | United States | 2016-2022 | MedCore

The value of the U.S. market for breast localization wires is expected to decline over the forecast period. Contraction will be driven by unit sales declines and reinforced by modest erosion in the ASP of breast localization wires.

more...

Breast Tissue Markers Market Analysis | United States | 2016-2022 | MedCore

The value of the U.S. breast tissue marker market is expected to increase modestly over the forecast period. Growth in the value of the market will be driven by increasing unit sales and limited by ASP erosion. The increasing incidence of breast cancer and utilization of breast tissue markers in percutaneous breast biopsies as well as axillary lymph node marking are expected to fuel unit sales growth over the next seven years. ASP erosion will be driven by commoditization of breast tissue markers with lower clinical value.

more...